Editorial: nocebo effect and switching to biosimilars Article Swipe
Adriaan A. van Bodegraven
,
Niels Boone
·
YOU?
·
· 2018
· Open Access
·
· DOI: https://doi.org/10.1111/apt.14509
YOU?
·
· 2018
· Open Access
·
· DOI: https://doi.org/10.1111/apt.14509
Linked content This article is linked to Schmitz et al paper. To view this article visit https://doi.org/10.1111/apt.14453 .
Related Topics
Concepts
Biosimilar
Nocebo Effect
Medicine
Nocebo
MEDLINE
Placebo
Alternative medicine
Internal medicine
Pathology
Law
Political science
Metadata
- Type
- editorial
- Language
- en
- Landing Page
- https://doi.org/10.1111/apt.14509
- https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/apt.14509
- OA Status
- bronze
- Cited By
- 4
- References
- 7
- Related Works
- 10
- OpenAlex ID
- https://openalex.org/W2793379347
All OpenAlex metadata
Raw OpenAlex JSON
- OpenAlex ID
-
https://openalex.org/W2793379347Canonical identifier for this work in OpenAlex
- DOI
-
https://doi.org/10.1111/apt.14509Digital Object Identifier
- Title
-
Editorial: nocebo effect and switching to biosimilarsWork title
- Type
-
editorialOpenAlex work type
- Language
-
enPrimary language
- Publication year
-
2018Year of publication
- Publication date
-
2018-02-15Full publication date if available
- Authors
-
Adriaan A. van Bodegraven, Niels BooneList of authors in order
- Landing page
-
https://doi.org/10.1111/apt.14509Publisher landing page
- PDF URL
-
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/apt.14509Direct link to full text PDF
- Open access
-
YesWhether a free full text is available
- OA status
-
bronzeOpen access status per OpenAlex
- OA URL
-
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/apt.14509Direct OA link when available
- Concepts
-
Biosimilar, Nocebo Effect, Medicine, Nocebo, MEDLINE, Placebo, Alternative medicine, Internal medicine, Pathology, Law, Political scienceTop concepts (fields/topics) attached by OpenAlex
- Cited by
-
4Total citation count in OpenAlex
- Citations by year (recent)
-
2022: 1, 2020: 2, 2019: 1Per-year citation counts (last 5 years)
- References (count)
-
7Number of works referenced by this work
- Related works (count)
-
10Other works algorithmically related by OpenAlex
Full payload
| id | https://openalex.org/W2793379347 |
|---|---|
| doi | https://doi.org/10.1111/apt.14509 |
| ids.doi | https://doi.org/10.1111/apt.14509 |
| ids.mag | 2793379347 |
| ids.pmid | https://pubmed.ncbi.nlm.nih.gov/29446141 |
| ids.openalex | https://openalex.org/W2793379347 |
| fwci | 0.36443508 |
| mesh[0].qualifier_ui | |
| mesh[0].descriptor_ui | D059451 |
| mesh[0].is_major_topic | True |
| mesh[0].qualifier_name | |
| mesh[0].descriptor_name | Biosimilar Pharmaceuticals |
| mesh[1].qualifier_ui | |
| mesh[1].descriptor_ui | D006801 |
| mesh[1].is_major_topic | False |
| mesh[1].qualifier_name | |
| mesh[1].descriptor_name | Humans |
| mesh[2].qualifier_ui | |
| mesh[2].descriptor_ui | D015212 |
| mesh[2].is_major_topic | True |
| mesh[2].qualifier_name | |
| mesh[2].descriptor_name | Inflammatory Bowel Diseases |
| mesh[3].qualifier_ui | |
| mesh[3].descriptor_ui | D000069285 |
| mesh[3].is_major_topic | False |
| mesh[3].qualifier_name | |
| mesh[3].descriptor_name | Infliximab |
| mesh[4].qualifier_ui | |
| mesh[4].descriptor_ui | D064786 |
| mesh[4].is_major_topic | False |
| mesh[4].qualifier_name | |
| mesh[4].descriptor_name | Nocebo Effect |
| mesh[5].qualifier_ui | |
| mesh[5].descriptor_ui | D011446 |
| mesh[5].is_major_topic | False |
| mesh[5].qualifier_name | |
| mesh[5].descriptor_name | Prospective Studies |
| mesh[6].qualifier_ui | |
| mesh[6].descriptor_ui | D059451 |
| mesh[6].is_major_topic | True |
| mesh[6].qualifier_name | |
| mesh[6].descriptor_name | Biosimilar Pharmaceuticals |
| mesh[7].qualifier_ui | |
| mesh[7].descriptor_ui | D006801 |
| mesh[7].is_major_topic | False |
| mesh[7].qualifier_name | |
| mesh[7].descriptor_name | Humans |
| mesh[8].qualifier_ui | |
| mesh[8].descriptor_ui | D015212 |
| mesh[8].is_major_topic | True |
| mesh[8].qualifier_name | |
| mesh[8].descriptor_name | Inflammatory Bowel Diseases |
| mesh[9].qualifier_ui | |
| mesh[9].descriptor_ui | D000069285 |
| mesh[9].is_major_topic | False |
| mesh[9].qualifier_name | |
| mesh[9].descriptor_name | Infliximab |
| mesh[10].qualifier_ui | |
| mesh[10].descriptor_ui | D064786 |
| mesh[10].is_major_topic | False |
| mesh[10].qualifier_name | |
| mesh[10].descriptor_name | Nocebo Effect |
| mesh[11].qualifier_ui | |
| mesh[11].descriptor_ui | D011446 |
| mesh[11].is_major_topic | False |
| mesh[11].qualifier_name | |
| mesh[11].descriptor_name | Prospective Studies |
| type | editorial |
| title | Editorial: nocebo effect and switching to biosimilars |
| biblio.issue | 6 |
| biblio.volume | 47 |
| biblio.last_page | 851 |
| biblio.first_page | 850 |
| topics[0].id | https://openalex.org/T12255 |
| topics[0].field.id | https://openalex.org/fields/24 |
| topics[0].field.display_name | Immunology and Microbiology |
| topics[0].score | 0.9991999864578247 |
| topics[0].domain.id | https://openalex.org/domains/1 |
| topics[0].domain.display_name | Life Sciences |
| topics[0].subfield.id | https://openalex.org/subfields/2403 |
| topics[0].subfield.display_name | Immunology |
| topics[0].display_name | Biosimilars and Bioanalytical Methods |
| topics[1].id | https://openalex.org/T11190 |
| topics[1].field.id | https://openalex.org/fields/22 |
| topics[1].field.display_name | Engineering |
| topics[1].score | 0.9269000291824341 |
| topics[1].domain.id | https://openalex.org/domains/3 |
| topics[1].domain.display_name | Physical Sciences |
| topics[1].subfield.id | https://openalex.org/subfields/2204 |
| topics[1].subfield.display_name | Biomedical Engineering |
| topics[1].display_name | 3D Printing in Biomedical Research |
| topics[2].id | https://openalex.org/T12547 |
| topics[2].field.id | https://openalex.org/fields/27 |
| topics[2].field.display_name | Medicine |
| topics[2].score | 0.9190000295639038 |
| topics[2].domain.id | https://openalex.org/domains/4 |
| topics[2].domain.display_name | Health Sciences |
| topics[2].subfield.id | https://openalex.org/subfields/2735 |
| topics[2].subfield.display_name | Pediatrics, Perinatology and Child Health |
| topics[2].display_name | Pharmaceutical studies and practices |
| is_xpac | False |
| apc_list.value | 5050 |
| apc_list.currency | USD |
| apc_list.value_usd | 5050 |
| apc_paid | |
| concepts[0].id | https://openalex.org/C59491497 |
| concepts[0].level | 2 |
| concepts[0].score | 0.9521141052246094 |
| concepts[0].wikidata | https://www.wikidata.org/wiki/Q864715 |
| concepts[0].display_name | Biosimilar |
| concepts[1].id | https://openalex.org/C2909182145 |
| concepts[1].level | 4 |
| concepts[1].score | 0.8947397470474243 |
| concepts[1].wikidata | https://www.wikidata.org/wiki/Q1332954 |
| concepts[1].display_name | Nocebo Effect |
| concepts[2].id | https://openalex.org/C71924100 |
| concepts[2].level | 0 |
| concepts[2].score | 0.8437813520431519 |
| concepts[2].wikidata | https://www.wikidata.org/wiki/Q11190 |
| concepts[2].display_name | Medicine |
| concepts[3].id | https://openalex.org/C2778360308 |
| concepts[3].level | 4 |
| concepts[3].score | 0.6160997748374939 |
| concepts[3].wikidata | https://www.wikidata.org/wiki/Q1332954 |
| concepts[3].display_name | Nocebo |
| concepts[4].id | https://openalex.org/C2779473830 |
| concepts[4].level | 2 |
| concepts[4].score | 0.4712025821208954 |
| concepts[4].wikidata | https://www.wikidata.org/wiki/Q1540899 |
| concepts[4].display_name | MEDLINE |
| concepts[5].id | https://openalex.org/C27081682 |
| concepts[5].level | 3 |
| concepts[5].score | 0.24975770711898804 |
| concepts[5].wikidata | https://www.wikidata.org/wiki/Q269829 |
| concepts[5].display_name | Placebo |
| concepts[6].id | https://openalex.org/C204787440 |
| concepts[6].level | 2 |
| concepts[6].score | 0.18634089827537537 |
| concepts[6].wikidata | https://www.wikidata.org/wiki/Q188504 |
| concepts[6].display_name | Alternative medicine |
| concepts[7].id | https://openalex.org/C126322002 |
| concepts[7].level | 1 |
| concepts[7].score | 0.16733530163764954 |
| concepts[7].wikidata | https://www.wikidata.org/wiki/Q11180 |
| concepts[7].display_name | Internal medicine |
| concepts[8].id | https://openalex.org/C142724271 |
| concepts[8].level | 1 |
| concepts[8].score | 0.0 |
| concepts[8].wikidata | https://www.wikidata.org/wiki/Q7208 |
| concepts[8].display_name | Pathology |
| concepts[9].id | https://openalex.org/C199539241 |
| concepts[9].level | 1 |
| concepts[9].score | 0.0 |
| concepts[9].wikidata | https://www.wikidata.org/wiki/Q7748 |
| concepts[9].display_name | Law |
| concepts[10].id | https://openalex.org/C17744445 |
| concepts[10].level | 0 |
| concepts[10].score | 0.0 |
| concepts[10].wikidata | https://www.wikidata.org/wiki/Q36442 |
| concepts[10].display_name | Political science |
| keywords[0].id | https://openalex.org/keywords/biosimilar |
| keywords[0].score | 0.9521141052246094 |
| keywords[0].display_name | Biosimilar |
| keywords[1].id | https://openalex.org/keywords/nocebo-effect |
| keywords[1].score | 0.8947397470474243 |
| keywords[1].display_name | Nocebo Effect |
| keywords[2].id | https://openalex.org/keywords/medicine |
| keywords[2].score | 0.8437813520431519 |
| keywords[2].display_name | Medicine |
| keywords[3].id | https://openalex.org/keywords/nocebo |
| keywords[3].score | 0.6160997748374939 |
| keywords[3].display_name | Nocebo |
| keywords[4].id | https://openalex.org/keywords/medline |
| keywords[4].score | 0.4712025821208954 |
| keywords[4].display_name | MEDLINE |
| keywords[5].id | https://openalex.org/keywords/placebo |
| keywords[5].score | 0.24975770711898804 |
| keywords[5].display_name | Placebo |
| keywords[6].id | https://openalex.org/keywords/alternative-medicine |
| keywords[6].score | 0.18634089827537537 |
| keywords[6].display_name | Alternative medicine |
| keywords[7].id | https://openalex.org/keywords/internal-medicine |
| keywords[7].score | 0.16733530163764954 |
| keywords[7].display_name | Internal medicine |
| language | en |
| locations[0].id | doi:10.1111/apt.14509 |
| locations[0].is_oa | True |
| locations[0].source.id | https://openalex.org/S158079644 |
| locations[0].source.issn | 0269-2813, 1365-2036 |
| locations[0].source.type | journal |
| locations[0].source.is_oa | False |
| locations[0].source.issn_l | 0269-2813 |
| locations[0].source.is_core | True |
| locations[0].source.is_in_doaj | False |
| locations[0].source.display_name | Alimentary Pharmacology & Therapeutics |
| locations[0].source.host_organization | https://openalex.org/P4310320595 |
| locations[0].source.host_organization_name | Wiley |
| locations[0].source.host_organization_lineage | https://openalex.org/P4310320595 |
| locations[0].source.host_organization_lineage_names | Wiley |
| locations[0].license | |
| locations[0].pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/apt.14509 |
| locations[0].version | publishedVersion |
| locations[0].raw_type | journal-article |
| locations[0].license_id | |
| locations[0].is_accepted | True |
| locations[0].is_published | True |
| locations[0].raw_source_name | Alimentary Pharmacology & Therapeutics |
| locations[0].landing_page_url | https://doi.org/10.1111/apt.14509 |
| locations[1].id | pmid:29446141 |
| locations[1].is_oa | False |
| locations[1].source.id | https://openalex.org/S4306525036 |
| locations[1].source.issn | |
| locations[1].source.type | repository |
| locations[1].source.is_oa | False |
| locations[1].source.issn_l | |
| locations[1].source.is_core | False |
| locations[1].source.is_in_doaj | False |
| locations[1].source.display_name | PubMed |
| locations[1].source.host_organization | https://openalex.org/I1299303238 |
| locations[1].source.host_organization_name | National Institutes of Health |
| locations[1].source.host_organization_lineage | https://openalex.org/I1299303238 |
| locations[1].license | |
| locations[1].pdf_url | |
| locations[1].version | publishedVersion |
| locations[1].raw_type | |
| locations[1].license_id | |
| locations[1].is_accepted | True |
| locations[1].is_published | True |
| locations[1].raw_source_name | Alimentary pharmacology & therapeutics |
| locations[1].landing_page_url | https://pubmed.ncbi.nlm.nih.gov/29446141 |
| locations[2].id | pmh:vumc:oai:pure.atira.dk:publications/dafd311a-207c-4264-adb0-7c33d02e42af |
| locations[2].is_oa | True |
| locations[2].source.id | https://openalex.org/S4306401843 |
| locations[2].source.issn | |
| locations[2].source.type | repository |
| locations[2].source.is_oa | False |
| locations[2].source.issn_l | |
| locations[2].source.is_core | False |
| locations[2].source.is_in_doaj | False |
| locations[2].source.display_name | Data Archiving and Networked Services (DANS) |
| locations[2].source.host_organization | https://openalex.org/I1322597698 |
| locations[2].source.host_organization_name | Royal Netherlands Academy of Arts and Sciences |
| locations[2].source.host_organization_lineage | https://openalex.org/I1322597698 |
| locations[2].license | other-oa |
| locations[2].pdf_url | |
| locations[2].version | submittedVersion |
| locations[2].raw_type | info:eu-repo/semantics/article |
| locations[2].license_id | https://openalex.org/licenses/other-oa |
| locations[2].is_accepted | False |
| locations[2].is_published | False |
| locations[2].raw_source_name | Alimentary Pharmacology and Therapeutics, 47(6), 850 - 851 |
| locations[2].landing_page_url | https://research.vumc.nl/en/publications/dafd311a-207c-4264-adb0-7c33d02e42af |
| indexed_in | crossref, pubmed |
| authorships[0].author.id | https://openalex.org/A5005045924 |
| authorships[0].author.orcid | https://orcid.org/0000-0003-2636-303X |
| authorships[0].author.display_name | Adriaan A. van Bodegraven |
| authorships[0].countries | NL |
| authorships[0].affiliations[0].institution_ids | https://openalex.org/I4210133559 |
| authorships[0].affiliations[0].raw_affiliation_string | Department of Gastroenterology, Zuyderland MC, Sittard-Geleen-Heerlen, The Netherlands |
| authorships[0].affiliations[1].institution_ids | https://openalex.org/I911458345 |
| authorships[0].affiliations[1].raw_affiliation_string | Department of Gastroenterology, VU University Medical Center, Amsterdam, The Netherlands |
| authorships[0].institutions[0].id | https://openalex.org/I911458345 |
| authorships[0].institutions[0].ror | https://ror.org/00q6h8f30 |
| authorships[0].institutions[0].type | healthcare |
| authorships[0].institutions[0].lineage | https://openalex.org/I4210151833, https://openalex.org/I911458345 |
| authorships[0].institutions[0].country_code | NL |
| authorships[0].institutions[0].display_name | Amsterdam UMC Location Vrije Universiteit Amsterdam |
| authorships[0].institutions[1].id | https://openalex.org/I4210133559 |
| authorships[0].institutions[1].ror | https://ror.org/03bfc4534 |
| authorships[0].institutions[1].type | healthcare |
| authorships[0].institutions[1].lineage | https://openalex.org/I4210133559, https://openalex.org/I4210166163 |
| authorships[0].institutions[1].country_code | NL |
| authorships[0].institutions[1].display_name | Zuyderland Medisch Centrum |
| authorships[0].author_position | first |
| authorships[0].raw_author_name | A. A. van Bodegraven |
| authorships[0].is_corresponding | True |
| authorships[0].raw_affiliation_strings | Department of Gastroenterology, VU University Medical Center, Amsterdam, The Netherlands, Department of Gastroenterology, Zuyderland MC, Sittard-Geleen-Heerlen, The Netherlands |
| authorships[1].author.id | https://openalex.org/A5028360298 |
| authorships[1].author.orcid | https://orcid.org/0000-0002-4236-2726 |
| authorships[1].author.display_name | Niels Boone |
| authorships[1].countries | NL |
| authorships[1].affiliations[0].institution_ids | https://openalex.org/I4210133559 |
| authorships[1].affiliations[0].raw_affiliation_string | Department of Clinical Pharmacy, Zuyderland MC, Sittard-Geleen-Heerlen, The Netherlands |
| authorships[1].institutions[0].id | https://openalex.org/I4210133559 |
| authorships[1].institutions[0].ror | https://ror.org/03bfc4534 |
| authorships[1].institutions[0].type | healthcare |
| authorships[1].institutions[0].lineage | https://openalex.org/I4210133559, https://openalex.org/I4210166163 |
| authorships[1].institutions[0].country_code | NL |
| authorships[1].institutions[0].display_name | Zuyderland Medisch Centrum |
| authorships[1].author_position | last |
| authorships[1].raw_author_name | N. W. Boone |
| authorships[1].is_corresponding | False |
| authorships[1].raw_affiliation_strings | Department of Clinical Pharmacy, Zuyderland MC, Sittard-Geleen-Heerlen, The Netherlands |
| has_content.pdf | True |
| has_content.grobid_xml | True |
| is_paratext | False |
| open_access.is_oa | True |
| open_access.oa_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/apt.14509 |
| open_access.oa_status | bronze |
| open_access.any_repository_has_fulltext | False |
| created_date | 2025-10-10T00:00:00 |
| display_name | Editorial: nocebo effect and switching to biosimilars |
| has_fulltext | False |
| is_retracted | False |
| updated_date | 2025-11-06T03:46:38.306776 |
| primary_topic.id | https://openalex.org/T12255 |
| primary_topic.field.id | https://openalex.org/fields/24 |
| primary_topic.field.display_name | Immunology and Microbiology |
| primary_topic.score | 0.9991999864578247 |
| primary_topic.domain.id | https://openalex.org/domains/1 |
| primary_topic.domain.display_name | Life Sciences |
| primary_topic.subfield.id | https://openalex.org/subfields/2403 |
| primary_topic.subfield.display_name | Immunology |
| primary_topic.display_name | Biosimilars and Bioanalytical Methods |
| related_works | https://openalex.org/W2906546995, https://openalex.org/W2894239243, https://openalex.org/W2885292041, https://openalex.org/W3000625420, https://openalex.org/W2806623595, https://openalex.org/W2810521786, https://openalex.org/W2989858130, https://openalex.org/W4316923544, https://openalex.org/W4379795999, https://openalex.org/W2930414230 |
| cited_by_count | 4 |
| counts_by_year[0].year | 2022 |
| counts_by_year[0].cited_by_count | 1 |
| counts_by_year[1].year | 2020 |
| counts_by_year[1].cited_by_count | 2 |
| counts_by_year[2].year | 2019 |
| counts_by_year[2].cited_by_count | 1 |
| locations_count | 3 |
| best_oa_location.id | doi:10.1111/apt.14509 |
| best_oa_location.is_oa | True |
| best_oa_location.source.id | https://openalex.org/S158079644 |
| best_oa_location.source.issn | 0269-2813, 1365-2036 |
| best_oa_location.source.type | journal |
| best_oa_location.source.is_oa | False |
| best_oa_location.source.issn_l | 0269-2813 |
| best_oa_location.source.is_core | True |
| best_oa_location.source.is_in_doaj | False |
| best_oa_location.source.display_name | Alimentary Pharmacology & Therapeutics |
| best_oa_location.source.host_organization | https://openalex.org/P4310320595 |
| best_oa_location.source.host_organization_name | Wiley |
| best_oa_location.source.host_organization_lineage | https://openalex.org/P4310320595 |
| best_oa_location.source.host_organization_lineage_names | Wiley |
| best_oa_location.license | |
| best_oa_location.pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/apt.14509 |
| best_oa_location.version | publishedVersion |
| best_oa_location.raw_type | journal-article |
| best_oa_location.license_id | |
| best_oa_location.is_accepted | True |
| best_oa_location.is_published | True |
| best_oa_location.raw_source_name | Alimentary Pharmacology & Therapeutics |
| best_oa_location.landing_page_url | https://doi.org/10.1111/apt.14509 |
| primary_location.id | doi:10.1111/apt.14509 |
| primary_location.is_oa | True |
| primary_location.source.id | https://openalex.org/S158079644 |
| primary_location.source.issn | 0269-2813, 1365-2036 |
| primary_location.source.type | journal |
| primary_location.source.is_oa | False |
| primary_location.source.issn_l | 0269-2813 |
| primary_location.source.is_core | True |
| primary_location.source.is_in_doaj | False |
| primary_location.source.display_name | Alimentary Pharmacology & Therapeutics |
| primary_location.source.host_organization | https://openalex.org/P4310320595 |
| primary_location.source.host_organization_name | Wiley |
| primary_location.source.host_organization_lineage | https://openalex.org/P4310320595 |
| primary_location.source.host_organization_lineage_names | Wiley |
| primary_location.license | |
| primary_location.pdf_url | https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/apt.14509 |
| primary_location.version | publishedVersion |
| primary_location.raw_type | journal-article |
| primary_location.license_id | |
| primary_location.is_accepted | True |
| primary_location.is_published | True |
| primary_location.raw_source_name | Alimentary Pharmacology & Therapeutics |
| primary_location.landing_page_url | https://doi.org/10.1111/apt.14509 |
| publication_date | 2018-02-15 |
| publication_year | 2018 |
| referenced_works | https://openalex.org/W2398448526, https://openalex.org/W2613299853, https://openalex.org/W2774116866, https://openalex.org/W2610308940, https://openalex.org/W2106152050, https://openalex.org/W2030711540, https://openalex.org/W2502393457 |
| referenced_works_count | 7 |
| abstract_inverted_index.. | 17 |
| abstract_inverted_index.To | 11 |
| abstract_inverted_index.al | 9 |
| abstract_inverted_index.et | 8 |
| abstract_inverted_index.is | 4 |
| abstract_inverted_index.to | 6 |
| abstract_inverted_index.This | 2 |
| abstract_inverted_index.this | 13 |
| abstract_inverted_index.view | 12 |
| abstract_inverted_index.visit | 15 |
| abstract_inverted_index.Linked | 0 |
| abstract_inverted_index.linked | 5 |
| abstract_inverted_index.paper. | 10 |
| abstract_inverted_index.Schmitz | 7 |
| abstract_inverted_index.article | 3, 14 |
| abstract_inverted_index.content | 1 |
| abstract_inverted_index.https://doi.org/10.1111/apt.14453 | 16 |
| cited_by_percentile_year.max | 96 |
| cited_by_percentile_year.min | 89 |
| corresponding_author_ids | https://openalex.org/A5005045924 |
| countries_distinct_count | 1 |
| institutions_distinct_count | 2 |
| corresponding_institution_ids | https://openalex.org/I4210133559, https://openalex.org/I911458345 |
| citation_normalized_percentile.value | 0.54608204 |
| citation_normalized_percentile.is_in_top_1_percent | False |
| citation_normalized_percentile.is_in_top_10_percent | False |